{
    "organizations": [],
    "uuid": "f1bff812d09e3cb8eb8eeaeb949b0c4d48ba55ec",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-adma-biologics-retires-about-86-mi/brief-adma-biologics-retires-about-8-6-million-shares-previously-issued-to-biotest-idUSFWN1SL160",
    "ord_in_thread": 0,
    "title": "BRIEF-ADMA Biologics Retires About 8.6 Million Shares Previously Issued to Biotest",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 14 (Reuters) - ADMA Biologics Inc:\n* ADMA BIOLOGICS INC - RETIRES APPROXIMATELY 8.6 MILLION SHARES PREVIOUSLY ISSUED TO BIOTEST PHARMACEUTICALS CORPORATION AND ITS FORMER PARENT, BIOTEST AG\n* ADMA BIOLOGICS - BPC WILL TRANSFER ABOUT 8.6 MILLION SHARES OF ADMA’S NON-VOTING COMMON STOCK BACK TO ADMA\n* ADMA BIOLOGICS - RETIREMENT OF ABOUT 8.6 MILLION SHARES FOR WAIVER AND RELEASE OF CERTAIN ADMA RIGHTS UNDER AGREEMENT, DATED AS OF JANUARY 21, 2017\n* ADMA BIOLOGICS INC - BPC WILL WAIVE AND TERMINATE ALL RIGHTS TO NAME A DIRECTOR AND OBSERVER TO ADMA’S BOARD OF DIRECTORS\n* ADMA BIOLOGICS - ADMA WILL TERMINATE RIGHTS TO REPURCHASE 2 ADMA BIOCENTERS WHICH CO HAD PREVIOUSLY AGREED TO TRANSFER TO BPC ON JANUARY 1, 2019. Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. 0 : 0 narrow-browser-and-phone medium-browser-and-portrait-tablet landscape-tablet medium-wide-browser wide-browser-and-larger medium-browser-and-landscape-tablet medium-wide-browser-and-larger above-phone portrait-tablet-and-above above-portrait-tablet landscape-tablet-and-above landscape-tablet-and-medium-wide-browser portrait-tablet-and-below landscape-tablet-and-below Apps Newsletters Reuters Plus Advertising Guidelines Cookies Terms of Use Privacy\nAll Quote: s delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.\n© 2018 Reuters. All Rights Reserved.",
    "published": "2018-05-15T01:23:00.000+03:00",
    "crawled": "2018-05-15T13:43:54.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "adma",
        "biologics",
        "inc",
        "adma",
        "biologics",
        "inc",
        "retires",
        "approximately",
        "million",
        "share",
        "previously",
        "issued",
        "biotest",
        "pharmaceutical",
        "corporation",
        "former",
        "parent",
        "biotest",
        "ag",
        "adma",
        "biologics",
        "bpc",
        "transfer",
        "million",
        "share",
        "adma",
        "common",
        "stock",
        "back",
        "adma",
        "adma",
        "biologics",
        "retirement",
        "million",
        "share",
        "waiver",
        "release",
        "certain",
        "adma",
        "right",
        "agreement",
        "dated",
        "january",
        "adma",
        "biologics",
        "inc",
        "bpc",
        "waive",
        "terminate",
        "right",
        "name",
        "director",
        "observer",
        "adma",
        "board",
        "director",
        "adma",
        "biologics",
        "adma",
        "terminate",
        "right",
        "repurchase",
        "adma",
        "biocenters",
        "co",
        "previously",
        "agreed",
        "transfer",
        "bpc",
        "january",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle",
        "apps",
        "newsletter",
        "reuters",
        "plus",
        "advertising",
        "guideline",
        "cooky",
        "term",
        "use",
        "privacy",
        "quote",
        "delayed",
        "minimum",
        "minute",
        "see",
        "complete",
        "list",
        "exchange",
        "delay",
        "reuters",
        "right",
        "reserved"
    ]
}